Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Scopus BioPharma Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 14 | 21 | +7 |
| Shares | 275.0K | 2.88M | +2.61M (+947.5%) |
| Value | $1.14M | $4.71M | +$3.57M (+313.3%) |
New holders (8)
Institutions that held Scopus BioPharma Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,100,000 | $3.43M | 0.08% |
| Vanguard Group Inc | 363,041 | $594.0K | 0.00% |
| Geode Capital Management, LLC | 66,121 | $108.0K | 0.00% |
| Two Sigma Investments, LP | 30,403 | $50.0K | 0.00% |
| Renaissance Technologies LLC | 20,900 | $34.0K | 0.00% |
| Citadel Advisors LLC | 20,897 | $34.0K | 0.00% |
| Virtu Financial LLC | 15,031 | $25.0K | 0.00% |
| Northern Trust Corp | 12,516 | $20.0K | 0.00% |
Sold out (1)
Institutions that held Scopus BioPharma Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| FMR LLC | 100 | $0 |